All updated as on -
During the projection period (2023-2030), the hyaluronic acid market is expected to expand from its 2022 valuation of USD 6.9 billion to a peak of USD 20.9 billion by 2030, a CAGR of 8.91%. The popularity of cosmetic procedures and the availability of hyaluronic acid-based beauty products both show no signs of slowing down.
The rising availability of both plastic surgeons and cosmetic clinics can be directly attributed to this upward trend in the rate of aesthetic procedures. The increasing popularity of noninvasive cosmetic procedures like Botox and injectable hyaluronic acid are fueling the market. It is expected that mergers and acquisitions, as well as the introduction of new products, will drive the market forward during the next several years. Hyaluronic acids' rising demand can be attributed to the several positive health effects they have, including their ability to retain water, speed wound healing, reduce joint pain, alleviate dry eyes and discomfort, and protect bone density.
The skin benefits of hyaluronic acid are well-known, and include the reduction of fine lines, wrinkles, redness, and dermatitis, as well as the relief of dry skin. Hyaluronic acid is a great moisturizer because it can bind to and hold 1,000 times its weight in water within the skin's cells. It aids in the skin's ability to retain moisture, boost collagen formation, protect against free radicals, and keep its elasticity. It also serves as a humectant, a type of hygroscopic skincare component that attracts moisture from its immediate environment. Manufacturers of personal care goods are following the consumer trend toward products that combine various functions and ingredients in an effort to meet the rising demand for anti-aging and other multipurpose products. In 2020, the United Nations estimated that there were 727 million people aged 65 and up, and that number is expected to more than double, to 1.5 billion by 2050. By 2050, the global elderly population is projected to increase from 9.3 percent in 2020 to 16.1 percent. Increased use of anti-aging skin care products is anticipated as the global population rises; this will drive up the need for hyaluronic acid. The effects of the COVID-19 are unknown, and this ambiguity has spread to the medical aesthetics business. The medical aesthetics industry has taken a major hit due to the COVID-19 crisis, which has mandated people keep their distance from others and forced customers to drastically reduce their discretionary spending.
The glycosaminoglycan hyaluronic acid (HA), also known as hyaluronan, is widely dispersed in the body's connective, epithelial, and neural tissues. Hyaluronic acid is a crucial component of articular cartilage, acting as a sheath around each cartilage cell (chondrocyte). Cartilage's sturdiness (its resistance to compression) stems from its aggregates' ability to absorb water. Although the total amount of hyaluronan in cartilage grows older, its molecular weight (size) shrinks. The human body produces its own HA. The highest concentrations of HA are seen in the eyes and joints. The chemical can help keep the skin soft and supple. Therefore, many cosmetic surgeons utilize it as an injection to prevent skin aging.
Market expansion in the forecast period is expected to be led by factors such as the increased prevalence of minimally invasive treatments and the rising awareness and demand for hyaluronic acid in pharmaceutical and cosmetic products throughout the globe. Various strategic actions done by market companies are responsible for the substantial improvement in the quality of research and the expansion of research opportunities. Over the years, they have taken several initiatives—including the introduction of new products and services, the formation of partnerships, the completion of mergers and acquisitions, and the creation of countless new business prospects.
The amount of hyaluronic acid in human skin can decrease with the passage of time, tobacco use, and environmental pollutants. Hyaluronic acid supplements and serums can help you avoid this and give your skin a healthy glow. New product approvals and mergers & acquisitions among industry participants have led to the introduction of cutting-edge technology and the expansion of operations into new geographies. Bioventus introduced Durolane, a single-injection joint lubricant for the treatment of knee osteoarthritis pain, in the United States in March 2018. Bioventus is the only U.S. manufacturer of hyaluronic acid injections for knee osteoarthritis pain, with one-injection (Durolane), three-injection (Gelsyn-3), and five-injection (Supartz FX) choices available.
Report Coverage
Global Hyaluronic Acid research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Hyaluronic Acid report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Hyaluronic Acid competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Hyaluronic Acid market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Hyaluronic Acid market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Hyaluronic Acid market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Allergan (Ireland), Sanofi (France), Genzyme Corporation (US), Seikagaku Corporation (Japan), F. Hoffmann-La Roche Ag (Switzerland), Zimmer Biomet (US), Smith & Nephew Plc (UK), Fidia Farmaceutici S.p.A., AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH,Kewpie Corporation, Merz North America, Inc., LABORATOIRES FILLMED , Prollenium Medical Technologies.,Huons, Contipro a.s., Lifecore Biomedical, Inc., BioScience GmbH,Teoxane, Bioxis Pharmaceuticals, SHANDONG TOPSCIENCE BIOTECH CO., LTD., Bohus BioTech AB, RIVER PHARMA s.r.l., Symatese, Stanford Chemicals owned by Oceania International LLC, Bioiberica S.A.U., GENESIS pharmacy services, and Brickell Men's Products among others.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Hyaluronic Acid market based on the below-mentioned segments:
Global Hyaluronic Acid Market, By Grade
Cosmetic Grade
Pharmaceutical Grade
Food Grade
Global Hyaluronic Acid market, By Application
Aesthetics
Osteoarthritis
Pharmaceutical API
Cosmetics
Dietary Supplements
Ophthalmology
Others
Global Hyaluronic Acid Market, By End User
Pharmaceutical Industry
Dermatology Clinics
Cosmetic Surgery Centers
Others
Global Hyaluronic Acid market, Regional Analysis
The rising availability of both plastic surgeons and cosmetic clinics can be directly attributed to this upward trend in the rate of aesthetic procedures. The increasing popularity of noninvasive cosmetic procedures like Botox and injectable hyaluronic acid are fueling the market. It is expected that mergers and acquisitions, as well as the introduction of new products, will drive the market forward during the next several years. Hyaluronic acids' rising demand can be attributed to the several positive health effects they have, including their ability to retain water, speed wound healing, reduce joint pain, alleviate dry eyes and discomfort, and protect bone density.
The skin benefits of hyaluronic acid are well-known, and include the reduction of fine lines, wrinkles, redness, and dermatitis, as well as the relief of dry skin. Hyaluronic acid is a great moisturizer because it can bind to and hold 1,000 times its weight in water within the skin's cells. It aids in the skin's ability to retain moisture, boost collagen formation, protect against free radicals, and keep its elasticity. It also serves as a humectant, a type of hygroscopic skincare component that attracts moisture from its immediate environment. Manufacturers of personal care goods are following the consumer trend toward products that combine various functions and ingredients in an effort to meet the rising demand for anti-aging and other multipurpose products. In 2020, the United Nations estimated that there were 727 million people aged 65 and up, and that number is expected to more than double, to 1.5 billion by 2050. By 2050, the global elderly population is projected to increase from 9.3 percent in 2020 to 16.1 percent. Increased use of anti-aging skin care products is anticipated as the global population rises; this will drive up the need for hyaluronic acid. The effects of the COVID-19 are unknown, and this ambiguity has spread to the medical aesthetics business. The medical aesthetics industry has taken a major hit due to the COVID-19 crisis, which has mandated people keep their distance from others and forced customers to drastically reduce their discretionary spending.
The glycosaminoglycan hyaluronic acid (HA), also known as hyaluronan, is widely dispersed in the body's connective, epithelial, and neural tissues. Hyaluronic acid is a crucial component of articular cartilage, acting as a sheath around each cartilage cell (chondrocyte). Cartilage's sturdiness (its resistance to compression) stems from its aggregates' ability to absorb water. Although the total amount of hyaluronan in cartilage grows older, its molecular weight (size) shrinks. The human body produces its own HA. The highest concentrations of HA are seen in the eyes and joints. The chemical can help keep the skin soft and supple. Therefore, many cosmetic surgeons utilize it as an injection to prevent skin aging.
Market expansion in the forecast period is expected to be led by factors such as the increased prevalence of minimally invasive treatments and the rising awareness and demand for hyaluronic acid in pharmaceutical and cosmetic products throughout the globe. Various strategic actions done by market companies are responsible for the substantial improvement in the quality of research and the expansion of research opportunities. Over the years, they have taken several initiatives—including the introduction of new products and services, the formation of partnerships, the completion of mergers and acquisitions, and the creation of countless new business prospects.
The amount of hyaluronic acid in human skin can decrease with the passage of time, tobacco use, and environmental pollutants. Hyaluronic acid supplements and serums can help you avoid this and give your skin a healthy glow. New product approvals and mergers & acquisitions among industry participants have led to the introduction of cutting-edge technology and the expansion of operations into new geographies. Bioventus introduced Durolane, a single-injection joint lubricant for the treatment of knee osteoarthritis pain, in the United States in March 2018. Bioventus is the only U.S. manufacturer of hyaluronic acid injections for knee osteoarthritis pain, with one-injection (Durolane), three-injection (Gelsyn-3), and five-injection (Supartz FX) choices available.
Report Coverage
Global Hyaluronic Acid research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Hyaluronic Acid report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Hyaluronic Acid competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Hyaluronic Acid market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Allergan (Ireland), Sanofi (France), Genzyme Corporation (US), Seikagaku Corporation (Japan), F. Hoffmann-La Roche Ag (Switzerland), Zimmer Biomet (US), Smith & Nephew Plc (UK), Fidia Farmaceutici S.p.A., AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH,Kewpie Corporation, Merz North America, Inc., LABORATOIRES FILLMED , Prollenium Medical Technologies.,Huons, Contipro a.s., Lifecore Biomedical, Inc., BioScience GmbH,Teoxane, Bioxis Pharmaceuticals, SHANDONG TOPSCIENCE BIOTECH CO., LTD., Bohus BioTech AB, RIVER PHARMA s.r.l., Symatese, Stanford Chemicals owned by Oceania International LLC, Bioiberica S.A.U., GENESIS pharmacy services, and Brickell Men's Products among others. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Hyaluronic Acid Market from 2021 to 2030.
- Market Forecast for Hyaluronic Acid Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Hyaluronic Acid competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Hyaluronic Acid
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Hyaluronic Acid market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Hyaluronic Acid market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Allergan (Ireland), Sanofi (France), Genzyme Corporation (US), Seikagaku Corporation (Japan), F. Hoffmann-La Roche Ag (Switzerland), Zimmer Biomet (US), Smith & Nephew Plc (UK), Fidia Farmaceutici S.p.A., AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH,Kewpie Corporation, Merz North America, Inc., LABORATOIRES FILLMED , Prollenium Medical Technologies.,Huons, Contipro a.s., Lifecore Biomedical, Inc., BioScience GmbH,Teoxane, Bioxis Pharmaceuticals, SHANDONG TOPSCIENCE BIOTECH CO., LTD., Bohus BioTech AB, RIVER PHARMA s.r.l., Symatese, Stanford Chemicals owned by Oceania International LLC, Bioiberica S.A.U., GENESIS pharmacy services, and Brickell Men's Products among others.
Primary Target Market
- Market Players of Hyaluronic Acid
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Hyaluronic Acid market based on the below-mentioned segments:
Global Hyaluronic Acid Market, By Grade
Cosmetic Grade
Pharmaceutical Grade
Food Grade
Global Hyaluronic Acid market, By Application
Aesthetics
Osteoarthritis
Pharmaceutical API
Cosmetics
Dietary Supplements
Ophthalmology
Others
Global Hyaluronic Acid Market, By End User
Pharmaceutical Industry
Dermatology Clinics
Cosmetic Surgery Centers
Others
Global Hyaluronic Acid market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive hyaluronic acid market market research and competitor analysis for your business to help you develop more profound insights into the hyaluronic acid market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the hyaluronic acid market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.